In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Generation Bio Co (NASDAQ: GBIO) closed at $0.37 up 2.89% from its previous closing price of $0.36. In other words, the price has increased by $2.89% from its previous closing price. On the day, 0.53 million shares were traded. GBIO stock price reached its highest trading level at $0.375 during the session, while it also had its lowest trading level at $0.3611.
Ratios:
For a deeper understanding of Generation Bio Co’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.43 and its Current Ratio is at 8.43. In the meantime, Its Debt-to-Equity ratio is 1.19 whereas as Long-Term Debt/Eq ratio is at 1.07.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 10 ’25 when Quinn Anthony G. bought 125,791 shares for $0.96 per share. The transaction valued at 120,759 led to the insider holds 214,286 shares of the business.
Quinn Anthony G. bought 85,000 shares of GBIO for $82,450 on Jan 13 ’25. The Director now owns 299,286 shares after completing the transaction at $0.97 per share. On Jul 01 ’24, another insider, Paone Antoinette, who serves as the CHIEF OPERATING OFFICER of the company, sold 6,719 shares for $2.74 each. As a result, the insider received 18,410 and left with 13,807 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GBIO now has a Market Capitalization of 24823134 and an Enterprise Value of -45158852. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.01 while its Price-to-Book (P/B) ratio in mrq is 0.34. Its current Enterprise Value per Revenue stands at -1.839 whereas that against EBITDA is 0.653.
Stock Price History:
The Beta on a monthly basis for GBIO is 2.66, which has changed by -0.86785716 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, GBIO has reached a high of $3.65, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is -5.59%, while the 200-Day Moving Average is calculated to be -66.95%.
Shares Statistics:
For the past three months, GBIO has traded an average of 527.77K shares per day and 502520 over the past ten days. A total of 67.01M shares are outstanding, with a floating share count of 45.82M. Insiders hold about 31.65% of the company’s shares, while institutions hold 54.54% stake in the company. Shares short for GBIO as of 1748563200 were 1089640 with a Short Ratio of 2.06, compared to 1745971200 on 1132883. Therefore, it implies a Short% of Shares Outstanding of 1089640 and a Short% of Float of 2.3699999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
